Xiaoping Jin

机构：Kelun Group (China), Nanjing Medical University · ORCID：0000-0003-3593-5853

发表论文 67 篇 · 总被引 1119 次 · h-index 17

代表论文

• Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway (2016 · Biomedicine & Pharmacotherapy · 被引 105)
• An fluorescent aptasensor for sensitive detection of tumor marker based on the FRET of a sandwich structured QDs-AFP-AuNPs (2019 · Talanta · 被引 92)
• Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study (2023 · Annals of Oncology · 被引 79)
• Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke (2017 · Scientific Reports · 被引 75)
• Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 60)
• High serum levels of sclerostin and Dickkopf-1 are associated with acute ischaemic stroke (2016 · Atherosclerosis · 被引 56)